Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 252

1.

Phosphoregulation of Rad51/Rad52 by CDK1 functions as a molecular switch for cell cycle-specific activation of homologous recombination.

Lim G, Chang Y, Huh WK.

Sci Adv. 2020 Feb 7;6(6):eaay2669. doi: 10.1126/sciadv.aay2669. eCollection 2020 Feb.

PMID:
32083180
2.

Phase II evaluation of copanlisib, a selective inhibitor of Pi3kca, in patients with persistent or recurrent endometrial carcinoma harboring PIK3CA hotspot mutations: An NRG Oncology study (NRG-GY008).

Santin AD, Filiaci V, Bellone S, Ratner ES, Mathews CA, Cantuaria G, Gunderson CC, Rutledge T, Buttin BM, Lankes HA, Frumovitz M, Khleif SN, Huh WK, Birrer MJ.

Gynecol Oncol Rep. 2020 Jan 2;31:100532. doi: 10.1016/j.gore.2019.100532. eCollection 2020 Feb.

3.

Cauda equina syndrome in an ovarian malignant-mixed müllerian tumor with leptomeningeal spread.

Bernstock JD, Ostby S, Fox B, Sotoudeh H, Janssen A, Kang YJ, Chen J, Prattipati V, Elsayed G, Chagoya G, Yamashita D, Friedman GK, Nabors B, Huh WK, Lobbous M.

Clin Case Rep. 2019 Oct 22;7(12):2341-2345. doi: 10.1002/ccr3.2472. eCollection 2019 Dec.

4.

Corrigendum to: Molecular Characterization of Adenylyl Cyclase Complex Proteins Using Versatile Protein-Tagging Plasmid Systems in Cryptococcus neoformans.

So YS, Yang DH, Jung KW, Huh WK, Bahn YS.

J Microbiol Biotechnol. 2019 Dec 28;29(12):2026. doi: 10.4014/jmb.2019.2912.2026.

5.

Human papillomavirus vaccination: Ongoing challenges and future directions.

Dilley S, Miller KM, Huh WK.

Gynecol Oncol. 2020 Feb;156(2):498-502. doi: 10.1016/j.ygyno.2019.10.018. Epub 2019 Dec 14. Review.

PMID:
31848025
6.

Risk of subsequent malignant neoplasms after an index potentially-human papillomavirus (HPV)-associated cancers.

Wang M, Sharma A, Osazuwa-Peters N, Simpson MC, Schootman M, Piccirillo JF, Huh WK, Adjei Boakye E.

Cancer Epidemiol. 2020 Feb;64:101649. doi: 10.1016/j.canep.2019.101649. Epub 2019 Dec 6.

PMID:
31816512
7.

Extensive financial hardship among gynecologic cancer patients starting a new line of therapy.

Liang MI, Pisu M, Summerlin SS, Boitano TKL, Blanchard CT, Bhatia S, Huh WK.

Gynecol Oncol. 2020 Feb;156(2):271-277. doi: 10.1016/j.ygyno.2019.11.022. Epub 2019 Nov 23.

PMID:
31771866
8.

The Reliability of Intraoperative Assessment on Predicting Tumor Size, Myometrial Invasion, and Cervical Involvement in Patients With a Preoperative Diagnosis of Complex Atypical Hyperplasia or (Clinical Stage I) Endometrial Cancer: A Prospective Cohort Study.

Smith BQ, Boone JD, Thomas ED, Turner TB, McGwin G Jr, Stisher AM, Leath CA 3rd, Novak L, Huh WK.

Am J Clin Oncol. 2020 Feb;43(2):122-127. doi: 10.1097/COC.0000000000000643.

PMID:
31764025
9.

Combination checkpoint inhibitor therapy induces multiple immune major related adverse events in the treatment of vaginal melanoma: A cautionary case report.

Norwood TG, Wang MJ, Huh WK.

Gynecol Oncol Rep. 2019 Oct 31;30:100508. doi: 10.1016/j.gore.2019.100508. eCollection 2019 Nov.

10.

Gestational Trophoblastic Neoplasia, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.

Abu-Rustum NR, Yashar CM, Bean S, Bradley K, Campos SM, Chon HS, Chu C, Cohn D, Crispens MA, Damast S, Dorigo O, Eifel PJ, Fisher CM, Frederick P, Gaffney DK, Han E, Huh WK, Lurain JR, Mariani A, Mutch D, Nagel C, Nekhlyudov L, Fader AN, Remmenga SW, Reynolds RK, Sisodia R, Tillmanns T, Ueda S, Wyse E, McMillian NR, Scavone J.

J Natl Compr Canc Netw. 2019 Nov 1;17(11):1374-1391. doi: 10.6004/jnccn.2019.0053.

PMID:
31693991
11.

Approaches to triage optimization in HPV primary screening: Extended genotyping and p16/Ki-67 dual-stained cytology-Retrospective insights from ATHENA.

Stoler MH, Baker E, Boyle S, Aslam S, Ridder R, Huh WK, Wright TC Jr.

Int J Cancer. 2019 Sep 6. doi: 10.1002/ijc.32669. [Epub ahead of print]

PMID:
31490545
12.

Corrigendum to "Financial toxicity - An overlooked side effect" [Gynecol. Oncol. 150 (2018) 3-6].

Liang MI, Huh WK.

Gynecol Oncol. 2019 Aug;154(2):449. doi: 10.1016/j.ygyno.2019.05.020. Epub 2019 May 31. No abstract available.

PMID:
31160071
13.

Nine-valent HPV vaccine efficacy against related diseases and definitive therapy: comparison with historic placebo population.

Giuliano AR, Joura EA, Garland SM, Huh WK, Iversen OE, Kjaer SK, Ferenczy A, Kurman RJ, Ronnett BM, Stoler MH, Bautista OM, Moeller E, Ritter M, Shields C, Luxembourg A.

Gynecol Oncol. 2019 Jul;154(1):110-117. doi: 10.1016/j.ygyno.2019.03.253. Epub 2019 Apr 11.

14.

The efficacy and safety of Tipapkinogen Sovacivec therapeutic HPV vaccine in cervical intraepithelial neoplasia grades 2 and 3: Randomized controlled phase II trial with 2.5 years of follow-up.

Harper DM, Nieminen P, Donders G, Einstein MH, Garcia F, Huh WK, Stoler MH, Glavini K, Attley G, Limacher JM, Bastien B, Calleja E.

Gynecol Oncol. 2019 Jun;153(3):521-529. doi: 10.1016/j.ygyno.2019.03.250. Epub 2019 Apr 4.

15.

Comparative outcomes between robotic and abdominal radical hysterectomy for IB1 cervical cancer: Results from a single high volume institution.

Doo DW, Kirkland CT, Griswold LH, McGwin G, Huh WK, Leath CA 3rd, Kim KH.

Gynecol Oncol. 2019 May;153(2):242-247. doi: 10.1016/j.ygyno.2019.03.001. Epub 2019 Mar 6.

16.

Observed Colposcopy Practice in US Community-Based Clinics: The Retrospective Control Arm of the IMPROVE-COLPO Study.

Huh WK, Papagiannakis E, Gold MA.

J Low Genit Tract Dis. 2019 Apr;23(2):110-115. doi: 10.1097/LGT.0000000000000454.

17.

Genome-Wide Studies of Rho5-Interacting Proteins That Are Involved in Oxidant-Induced Cell Death in Budding Yeast.

Singh K, Lee ME, Entezari M, Jung CH, Kim Y, Park Y, Fioretti JD, Huh WK, Park HO, Kang PJ.

G3 (Bethesda). 2019 Mar 7;9(3):921-931. doi: 10.1534/g3.118.200887.

18.

Cervical Cancer, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology.

Koh WJ, Abu-Rustum NR, Bean S, Bradley K, Campos SM, Cho KR, Chon HS, Chu C, Clark R, Cohn D, Crispens MA, Damast S, Dorigo O, Eifel PJ, Fisher CM, Frederick P, Gaffney DK, Han E, Huh WK, Lurain JR, Mariani A, Mutch D, Nagel C, Nekhlyudov L, Fader AN, Remmenga SW, Reynolds RK, Tillmanns T, Ueda S, Wyse E, Yashar CM, McMillian NR, Scavone JL.

J Natl Compr Canc Netw. 2019 Jan;17(1):64-84. doi: 10.6004/jnccn.2019.0001.

PMID:
30659131
19.

Global analysis of protein homomerization in Saccharomyces cerevisiae.

Kim Y, Jung JP, Pack CG, Huh WK.

Genome Res. 2019 Jan;29(1):135-145. doi: 10.1101/gr.231860.117. Epub 2018 Dec 19.

20.

G2A Protects Mice against Sepsis by Modulating Kupffer Cell Activation: Cooperativity with Adenosine Receptor 2b.

Li HM, Jang JH, Jung JS, Shin J, Park CO, Kim YJ, Ahn WG, Nam JS, Hong CW, Lee J, Jung YJ, Chen JF, Ravid K, Lee HT, Huh WK, Kabarowski JH, Song DK.

J Immunol. 2019 Jan 15;202(2):527-538. doi: 10.4049/jimmunol.1700783. Epub 2018 Dec 10.

21.

The cost-effectiveness of opportunistic salpingectomy versus standard tubal ligation at the time of cesarean delivery for ovarian cancer risk reduction.

Subramaniam A, Einerson BD, Blanchard CT, Erickson BK, Szychowski J, Leath CA 3rd, Biggio JR, Huh WK.

Gynecol Oncol. 2019 Jan;152(1):127-132. doi: 10.1016/j.ygyno.2018.11.009. Epub 2018 Nov 23.

22.

A Ketogenic Diet Reduces Central Obesity and Serum Insulin in Women with Ovarian or Endometrial Cancer.

Cohen CW, Fontaine KR, Arend RC, Alvarez RD, Leath CA III, Huh WK, Bevis KS, Kim KH, Straughn JM Jr, Gower BA.

J Nutr. 2018 Aug 1;148(8):1253-1260. doi: 10.1093/jn/nxy119.

PMID:
30137481
23.

Quality Improvement to Demonstrate the Lack of Reliability of the Human Papillomavirus mRNA Assay to Identify Women With Latent Human Papillomavirus Infections.

Schiffman M, Huh WK, Stockdale CK, Einstein MH, Chelmow D, Flowers LC.

Obstet Gynecol. 2018 Sep;132(3):778-779. doi: 10.1097/AOG.0000000000002828. No abstract available.

24.

Human Papillomavirus Genotypes From Vaginal and Vulvar Intraepithelial Neoplasia in Females 15-26 Years of Age.

Garland SM, Joura EA, Ault KA, Bosch FX, Brown DR, Castellsagué X, Ferenczy A, Ferris DG, Giuliano AR, Hernandez-Avila M, Huh WK, Iversen OE, Kjaer SK, Kurman RJ, Luna J, Monsonego J, Muñoz N, Paavonen J, Pitisuttihum P, Ronnett BM, Steben M, Stoler MH, Wheeler CM, Wiley DJ, Perez G, Saah AJ, Luxembourg A, Li S, DiNubile MJ, Wagner M, Velicer C.

Obstet Gynecol. 2018 Aug;132(2):261-270. doi: 10.1097/AOG.0000000000002736.

PMID:
29995724
25.

Analysis of All 34 Exons of the SPINK5 Gene in Japanese Atopic Dermatitis Patients.

Morizane S, Ouchida M, Sunagawa K, Sugimoto S, Kobashi M, Sugihara S, Nomura H, Tsuji K, Sato A, Miura Y, Hattori H, Tada K, Huh WK, Seno A, Iwatsuki K.

Acta Med Okayama. 2018 Jun;72(3):275-282. doi: 10.18926/AMO/56073.

26.

Mitochondrial dysfunction reduces yeast replicative lifespan by elevating RAS-dependent ROS production by the ER-localized NADPH oxidase Yno1.

Yi DG, Hong S, Huh WK.

PLoS One. 2018 Jun 18;13(6):e0198619. doi: 10.1371/journal.pone.0198619. eCollection 2018.

27.

Feasibility of Complete Salpingectomy Compared With Standard Postpartum Tubal Ligation at Cesarean Delivery: A Randomized Controlled Trial.

Subramaniam A, Blanchard CT, Erickson BK, Szychowski J, Leath CA, Biggio JR, Huh WK.

Obstet Gynecol. 2018 Jul;132(1):20-27. doi: 10.1097/AOG.0000000000002646.

28.

The budding yeast RSC complex maintains ploidy by promoting spindle pole body insertion.

Sing TL, Hung MP, Ohnuki S, Suzuki G, San Luis BJ, McClain M, Unruh JR, Yu Z, Ou J, Marshall-Sheppard J, Huh WK, Costanzo M, Boone C, Ohya Y, Jaspersen SL, Brown GW.

J Cell Biol. 2018 Jul 2;217(7):2445-2462. doi: 10.1083/jcb.201709009. Epub 2018 Jun 6.

29.

In Defense of a Simplified, Practical Colposcopic Terminology.

Khan MJ, Massad LS, Huh WK, Wentzensen N.

J Low Genit Tract Dis. 2018 Jul;22(3):233-234. doi: 10.1097/LGT.0000000000000405. No abstract available.

PMID:
29794821
30.

Financial toxicity - An overlooked side effect.

Liang MI, Huh WK.

Gynecol Oncol. 2018 Jul;150(1):3-6. doi: 10.1016/j.ygyno.2018.05.012. Epub 2018 May 31. No abstract available. Erratum in: Gynecol Oncol. 2019 Aug;154(2):449.

31.

Access to gynecologic oncology care and the network adequacy standard.

Shalowitz DI, Huh WK.

Cancer. 2018 Jul 1;124(13):2677-2679. doi: 10.1002/cncr.31392. Epub 2018 May 16. No abstract available.

32.

Correlation between Surgeon's assessment and radiographic evaluation of residual disease in women with advanced stage ovarian cancer reported to have undergone optimal surgical cytoreduction: An NRG Oncology/Gynecologic Oncology Group study.

Eskander RN, Kauderer J, Tewari KS, Mannel RS, Bristow RE, O'Malley DM, Rubin SC, Glaser GE, Hamilton CA, Fujiwara K, Huh WK, Ueland F, Stephan JM, Burger RA.

Gynecol Oncol. 2018 Jun;149(3):525-530. doi: 10.1016/j.ygyno.2018.03.043. Epub 2018 Mar 15.

PMID:
29550184
33.

Molecular Response to Neoadjuvant Chemotherapy in High-Grade Serous Ovarian Carcinoma.

Arend RC, Londoño AI, Montgomery AM, Smith HJ, Dobbin ZC, Katre AA, Martinez A, Yang ES, Alvarez RD, Huh WK, Bevis KS, Straughn JM Jr, Estes JM, Novak L, Crossman DK, Cooper SJ, Landen CN, Leath CA 3rd.

Mol Cancer Res. 2018 May;16(5):813-824. doi: 10.1158/1541-7786.MCR-17-0594. Epub 2018 Mar 9.

34.

High Rates of High-Grade Cervical Dysplasia in High-Risk Young Women With Low-Grade Cervical Cytology.

Daily LR, Erickson BK, Pasko DN, Straughn JM Jr, Huh WK, Leath CA 3rd.

J Low Genit Tract Dis. 2018 Jul;22(3):207-211. doi: 10.1097/LGT.0000000000000381.

35.

Uterine Neoplasms, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology.

Koh WJ, Abu-Rustum NR, Bean S, Bradley K, Campos SM, Cho KR, Chon HS, Chu C, Cohn D, Crispens MA, Damast S, Dorigo O, Eifel PJ, Fisher CM, Frederick P, Gaffney DK, George S, Han E, Higgins S, Huh WK, Lurain JR 3rd, Mariani A, Mutch D, Nagel C, Nekhlyudov L, Fader AN, Remmenga SW, Reynolds RK, Tillmanns T, Ueda S, Wyse E, Yashar CM, McMillian NR, Scavone JL.

J Natl Compr Canc Netw. 2018 Feb;16(2):170-199. doi: 10.6004/jnccn.2018.0006.

PMID:
29439178
36.
37.

Targeted knockout of a chemokine-like gene increases anxiety and fear responses.

Choi JH, Jeong YM, Kim S, Lee B, Ariyasiri K, Kim HT, Jung SH, Hwang KS, Choi TI, Park CO, Huh WK, Carl M, Rosenfeld JA, Raskin S, Ma A, Gecz J, Kim HG, Kim JS, Shin HC, Park DS, Gerlai R, Jamieson BB, Kim JS, Iremonger KJ, Lee SH, Shin HS, Kim CH.

Proc Natl Acad Sci U S A. 2018 Jan 30;115(5):E1041-E1050. doi: 10.1073/pnas.1707663115. Epub 2018 Jan 16.

38.

Rad52 phosphorylation by Ipl1 and Mps1 contributes to Mps1 kinetochore localization and spindle assembly checkpoint regulation.

Lim G, Huh WK.

Proc Natl Acad Sci U S A. 2017 Oct 31;114(44):E9261-E9270. doi: 10.1073/pnas.1705261114. Epub 2017 Oct 16.

39.

Where Are the Opportunities for Reducing Health Care Spending Within Alternative Payment Models?

Rocque GB, Williams CP, Kenzik KM, Jackson BE, Halilova KI, Sullivan MM, Rocconi RP, Azuero A, Kvale EA, Huh WK, Partridge EE, Pisu M.

J Oncol Pract. 2018 Jun;14(6):e375-e383. doi: 10.1200/JOP.2017.024935. Epub 2017 Oct 5.

PMID:
28981388
40.

ASCCP Colposcopy Standards: Colposcopy Quality Improvement Recommendations for the United States.

Mayeaux EJ Jr, Novetsky AP, Chelmow D, Garcia F, Choma K, Liu AH, Papasozomenos T, Einstein MH, Massad LS, Wentzensen N, Waxman AG, Conageski C, Khan MJ, Huh WK.

J Low Genit Tract Dis. 2017 Oct;21(4):242-248. doi: 10.1097/LGT.0000000000000342.

41.

ASCCP Colposcopy Standards: How Do We Perform Colposcopy? Implications for Establishing Standards.

Waxman AG, Conageski C, Silver MI, Tedeschi C, Stier EA, Apgar B, Huh WK, Wentzensen N, Massad LS, Khan MJ, Mayeaux EJ Jr, Einstein MH, Schiffman MH, Guido RS.

J Low Genit Tract Dis. 2017 Oct;21(4):235-241. doi: 10.1097/LGT.0000000000000336.

42.

ASCCP Colposcopy Standards: Risk-Based Colposcopy Practice.

Wentzensen N, Schiffman M, Silver MI, Khan MJ, Perkins RB, Smith KM, Gage JC, Gold MA, Conageski C, Einstein MH, Mayeaux EJ Jr, Waxman AG, Huh WK, Massad LS.

J Low Genit Tract Dis. 2017 Oct;21(4):230-234. doi: 10.1097/LGT.0000000000000334.

PMID:
28953111
43.

ASCCP Colposcopy Standards: Role of Colposcopy, Benefits, Potential Harms, and Terminology for Colposcopic Practice.

Khan MJ, Werner CL, Darragh TM, Guido RS, Mathews C, Moscicki AB, Mitchell MM, Schiffman M, Wentzensen N, Massad LS, Mayeaux EJ Jr, Waxman AG, Conageski C, Einstein MH, Huh WK.

J Low Genit Tract Dis. 2017 Oct;21(4):223-229. doi: 10.1097/LGT.0000000000000338. Review.

PMID:
28953110
44.

Evidence-Based Consensus Recommendations for Colposcopy Practice for Cervical Cancer Prevention in the United States.

Wentzensen N, Massad LS, Mayeaux EJ Jr, Khan MJ, Waxman AG, Einstein MH, Conageski C, Schiffman MH, Gold MA, Apgar BS, Chelmow D, Choma KK, Darragh TM, Gage JC, Garcia FAR, Guido RS, Jeronimo JA, Liu A, Mathews CA, Mitchell MM, Moscicki AB, Novetsky AP, Papasozomenos T, Perkins RB, Silver MI, Smith KM, Stier EA, Tedeschi CA, Werner CL, Huh WK.

J Low Genit Tract Dis. 2017 Oct;21(4):216-222. doi: 10.1097/LGT.0000000000000322.

PMID:
28953109
45.

Lessons learned from domestic and international human papillomavirus vaccination programs: a review.

Miller K, Dilley SE, Huh WK.

Am J Obstet Gynecol. 2018 May;218(5):467-473. doi: 10.1016/j.ajog.2017.08.109. Epub 2017 Sep 6. Review.

PMID:
28888586
46.

Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16-26 years: a randomised, double-blind trial.

Huh WK, Joura EA, Giuliano AR, Iversen OE, de Andrade RP, Ault KA, Bartholomew D, Cestero RM, Fedrizzi EN, Hirschberg AL, Mayrand MH, Ruiz-Sternberg AM, Stapleton JT, Wiley DJ, Ferenczy A, Kurman R, Ronnett BM, Stoler MH, Cuzick J, Garland SM, Kjaer SK, Bautista OM, Haupt R, Moeller E, Ritter M, Roberts CC, Shields C, Luxembourg A.

Lancet. 2017 Nov 11;390(10108):2143-2159. doi: 10.1016/S0140-6736(17)31821-4. Epub 2017 Sep 5.

PMID:
28886907
47.

Optimizing secondary prevention of cervical cancer: Recent advances and future challenges.

Ogilvie G, Nakisige C, Huh WK, Mehrotra R, Franco EL, Jeronimo J.

Int J Gynaecol Obstet. 2017 Jul;138 Suppl 1:15-19. doi: 10.1002/ijgo.12187. Review.

PMID:
28691338
48.

The impact of physician burnout on clinical and academic productivity of gynecologic oncologists: A decision analysis.

Turner TB, Dilley SE, Smith HJ, Huh WK, Modesitt SC, Rose SL, Rice LW, Fowler JM, Straughn JM Jr.

Gynecol Oncol. 2017 Sep;146(3):642-646. doi: 10.1016/j.ygyno.2017.06.026. Epub 2017 Jun 24.

PMID:
28655413
49.

Will bevacizumab biosimilars impact the value of systemic therapy in gynecologic cancers?

Monk BJ, Huh WK, Rosenberg JA, Jacobs I.

Gynecol Oncol Res Pract. 2017 Mar 21;4:7. doi: 10.1186/s40661-017-0045-x. eCollection 2017. Review.

50.

Supplemental Content

Support Center